Skip to main content
Daily market wrap · Wednesday, 9 September 2026
~2 min read

Nifty -0.9%: tape hollowing out, not holding

Decliners beat advancers 1,576 to 908, net new highs collapsed to +8 — the bounce is over.
Stage2Stocks Market Desk
Nifty 50
23,432
-0.9% on the day
Regime
Transition
7th day · neutral-to-down
Breadth
42%
above 200-DMA · narrow
Adv / Dec
908 / 1,576
decliners ahead
52w highs / lows
179 / 171
net +8
Stage-2 share
33%
cohort narrowing

The Nifty 50 dropped 0.9% to 23,431.5, sitting below its 200-day average and 11% off its 52-week high. Decliners beat advancers 1,576 to 908, net new highs fell to just 8, and the Stage-2 cohort has shed ground for five straight days — this is not a dip inside strength. The regime has been in transition for seven days and the near-term read is neutral-to-down; today's tape confirms the deterioration, not a pause before a resumption.

Trajectory: the internals are cracking, not consolidating

The slow structural gauge — the share of stocks above their 200-day average — has slipped from 42.4% on 4 September to 41.7% today, a quiet but steady erosion. The fast short-term gauge, stocks above their 20-day average, peaked at 43.7% mid-week and has now retreated to 40.7%, confirming the brief mid-week bounce was exactly that — a bounce. Net new highs tell the same story: 72 on 4 September, 61 on 8 September, 8 today. Advance-decline has been negative in four of the last six sessions, and the 5-day Stage-2 flow shows 62 stocks moving from advancing to topping against only 29 moving the other way — distribution, not accumulation.

Leadership: defensive and thin, with pockets of structural work

Utilities led on the day at +1.1%, which is a defensive rotation signal, not a growth one; Industrials and Materials added 0.4% each but neither sector has done anything meaningful over one month. The Stage-2 cohort is expanding fastest inside Energy and Consumer Staples — not the cyclical leadership you want to see in a healthy tape. Among names that cleared the screen, Bliss GVS Pharma, with 40 weeks in stage and an RS rank of 99, stands out as a stock that has done its structural work regardless of the index — but in a market where the fast breadth gauge is rolling over and net new highs just printed 8, follow-through rates on even clean setups compress sharply.

Leading Stage-2 setups
StockSectorSetup% 1D
Oriental Aromatics LtdMaterials9.8
AVT Natural Products LtdConsumer Staples9.8
Indo Borax and Chemicals LtdMaterials9.4
Modison LtdIndustrials9.4
IOL Chemicals and Pharmaceuticals LtdMaterials9.4
Bliss GVS Pharma LtdHealth Care9.4
KRN Heat Exchanger and Refrigeration LtdIndustrials9.4
Manaksia Steels LtdMaterials9.4
Sector performance — cap-weighted, ranked by today’s move
Sector1D1M3MRSStage 2
Utilities+1.1%-2.7%-3.5%5619%
Industrials+0.4%+0.0%+8.4%6829%
Materials+0.4%-0.0%+5.4%6436%
Consumer Discretionary-0.2%-2.0%+13.7%6034%
Health Care-0.3%+0.7%+12.1%7147%
Energy-0.5%-2.3%+3.2%5848%
Communication Services-0.6%+0.1%+11.9%5924%
Consumer Staples-0.9%-5.0%-2.3%4335%
Financials-0.9%-2.6%+4.8%5934%
Real Estate-1.9%-0.9%+15.8%5327%
Information Technology-2.3%-6.9%+5.9%4426%
Breadth note
179 stocks are at or near new 52-week highs today — broad participation.
Work the same data live: open the full stock screener, watch the live market dashboard, or check the market-timing regime read. New to the method? Start with the four stages.

Stage2Stocks is an educational stage-analysis screener. These wraps describe what the screen shows across NSE cash equities — they are not investment advice, recommendations, or buy/sell calls. Always do your own research.

More market wraps